about
Nuclear and cytoplasmic c-Ski differently modulate cellular functionsHomozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsTGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transitionTransforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells.EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway.Tumor-promoting functions of transforming growth factor-β in progression of cancer.Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation.RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.AAG8 promotes carcinogenesis by activating STAT3.TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20.Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.ZEB1-regulated inflammatory phenotype in breast cancer cells.Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution.Autocrine BMP-4 Signaling Is a Therapeutic Target in Colorectal Cancer.TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling.Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells.ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets.A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim.Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasisTransforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1Intracellular and extracellular TGF-β signaling in cancer: some recent topicsEpigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasisc-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling
P50
Q24307865-5F5800A1-8B5E-4470-BB2D-E068786EDEC0Q24313224-56D88248-70B5-474C-9DF2-7B4C78712F18Q28512991-51CBDC7E-9D5D-4ED8-B488-C72D65BA3352Q35051669-CA0998C5-59C7-4056-8009-202BCC808001Q36882764-9A31442F-1CD7-41C8-B68D-54B43EC399F2Q37960077-B26DDE7C-F1FF-406B-8B08-6B1A0B64B041Q38115632-DFD8B7EE-B7E9-448F-8E5A-BE20F5A5964CQ38408653-9025A949-E564-4E29-8281-778D169B25D9Q38790417-2C310DFF-BDB0-40D1-8B6F-7F69FF4B538EQ38900293-0E7FB5E1-D0D7-4DF3-904E-F1A49D5C0C2EQ39004840-86A47260-F9F7-437D-B436-A5B45017A4AFQ39337154-0B070203-B5F1-4B57-B0FF-412E8F9F0B9BQ39359077-F9E7E04C-94B2-4C17-854C-7D3E533A617EQ39376769-AD2626C6-75F4-49C5-86C0-6A87A62EC81EQ39458618-F093F34F-EBFF-405E-917D-C4EF22FC24A2Q39623731-BAABDEAE-77A2-499E-82FF-871CB759C26AQ40171088-B0326337-57FD-401C-87B2-B1D43B638BFBQ40204082-2886BC0B-A6FB-4491-869A-726DE54E35AAQ42353340-50E0DE40-F5B3-45F8-8BFD-47F0601C3D34Q42498067-8D0CBBBD-EB9A-4E94-8C38-3DD911A54802Q48120175-641B4DB6-E010-4698-8F15-8B1CD964492BQ48208530-CA50367F-C9F3-40A9-9EEB-C5E017DAA37DQ48764141-B3B042DF-C1CB-4FE2-8933-62B1E3A5B0D2Q49194040-DD6A3320-7C65-47DE-9C1E-0E1783859ED9Q52671032-CE5EDCE0-9A5B-43E2-86E8-F548D29171FFQ52760854-3E45BB53-379E-45D6-B7D2-562528EC49A7Q53500903-2D5E0276-D47C-4F63-8668-DA336D0C17B1Q54647015-94D4B341-CBD3-4A3B-A0A5-3DFD89FAA3BEQ60921418-01117D61-9F75-4683-BD75-6C052B847AF2Q81454506-C1E2E328-621A-4C9D-8783-FC08AAF5DF22Q90457405-0B62BCEA-F33D-4E1D-A7EF-059B2585E87EQ90591301-93D8B0CF-E5B0-4A93-98F4-D5C3C0000A18Q93018784-6019BFBF-A623-47DA-8126-C576EFCD4340
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shogo Ehata
@ast
Shogo Ehata
@en
Shogo Ehata
@es
Shogo Ehata
@nl
Shogo Ehata
@sl
type
label
Shogo Ehata
@ast
Shogo Ehata
@en
Shogo Ehata
@es
Shogo Ehata
@nl
Shogo Ehata
@sl
prefLabel
Shogo Ehata
@ast
Shogo Ehata
@en
Shogo Ehata
@es
Shogo Ehata
@nl
Shogo Ehata
@sl
P106
P1153
9941369100
P31
P496
0000-0002-6740-9391